Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmaceutical News - MedExpress in talks to deliver morning-after pill by drone [Syrian Arab News Agency] - November 20, 2017

Pharmacy News Article

 9/8/17 - MedExpress in talks to deliver morning-after pill by drone [Syrian Arab News Agency]

An online pharmacy is planning to use drones to deliver the morning-after pill and Viagra following successful UK trials.

MedExpress is in talks with the independent regulator for pharmacy services to dispatch medicines and the contraceptive nationwide.

The company says the service will be particularly useful for people living in remote areas.

They have offered assurances that the products will be delivered discreetly with purchases details blacked out on sales records and bank accounts.

One challenge MedExpress faces is delivering medication safely and at temperatures that do not interfere with the drugs effectiveness.

But in the trial, the emergency contraception pill was carried at below 25C by a drone and successfully delivered in Broadstairs, Kent.

MedExpress has now filed an enquiry with The General Pharmaceutical Council. Managing director Dwayne DSouza said regulatory approval may take some time but the company hopes to launch the service as soon as possible.

He said: The rise of artificial intelligence, along with autonomous delivery and other sophisticated technologies, provides ample opportunity for businesses such as MedExpress to trial a range of convenient customer service options.

We were very pleased with how the trial went. Were considering making drone delivery part of our future service and are in talks to work out how we can do this.

Were confident our customers will love the idea.

A drone-based delivery system is currently in development by Amazon.com. It made its first commercial delivery using a drone, in the UK last December.

The package arrived safely at its destination in Cambridge, 13 minutes after being ordered.

A high street retailer has become the first to launch a generic emergency hormonal contraceptive pill (EHC) at half the price of branded versions prompting concerns it could result in a rise in ectopic pregnancies and STDs.

The morning-after pill set women back as much as 31.60 up to five times more compared to other areas of Europe.

That was until Superdrug, followed by Tesco, dropped their prices to just over 13. However, Boots has not followed suit and said it did not want to encourage over-use.

Ezinelle contains the same active ingredient as popular brand Levonelle and is said to be just as effective.

Health charities have urged other big retailers to drop their prices to make it more accessible.

But others warn the move could lead to higher rates of sexually transmitted diseases and ectopic pregnancies.



(c) International 2006-2017, SANA Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 20: Obesity Management: Overview of Pharmacotherapy
Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415